Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.creator | Gonzalez, A. (Arantxa) | - |
dc.creator | Lopez-Salazar, M.B. (María Begoña) | - |
dc.creator | Diez-Martinez, J. (Javier) | - |
dc.date.accessioned | 2012-05-05T17:03:45Z | - |
dc.date.available | 2012-05-05T17:03:45Z | - |
dc.date.issued | 2002 | - |
dc.identifier.citation | Gonzalez A, Lopez B, Diez J. Myocardial fibrosis in arterial hipertensión. Eur Heart J 2002;4(Supp D):D18-D22 | es_ES |
dc.identifier.issn | 1554-2815 | - |
dc.identifier.uri | https://hdl.handle.net/10171/21900 | - |
dc.description.abstract | It is now accepted that, in addition to left ventricular hypertrophy, hypertensive heart disease is characterized by alterations in myocardial structure, leading to loss of tissue homogeneity and pathological remodelling. It is time to recognize that, in hypertensive heart disease, it is not only the quantity but also the quality of the myocardium that is responsible for adverse cardiovascular events. The data reviewed here indicate that, in patients with hypertensive heart disease, myocardial fibrosis predisposes to an enhanced risk for diastolic and/or systolic ventricular dysfunction, symptomatic heart failure, ischaemic heart disease and arrhythmias. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Oxford University Press | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Fibrosis | es_ES |
dc.subject | Heart failure | es_ES |
dc.subject | Hypertension | es_ES |
dc.subject | Myocardium | es_ES |
dc.subject | Remodelling | es_ES |
dc.subject | Reparation | es_ES |
dc.title | Myocardial fibrosis in arterial hypertension | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | http://bit.ly/K1Kxql | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
Ficheros en este ítem:
Estadísticas e impacto
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.